首页/数据集/Erythroid-Specific Transcriptional Changes in PBMCs from Pulmonary Hypertension Patients

Erythroid-Specific Transcriptional Changes in PBMCs from Pulmonary Hypertension Patients

ChEBI2012-04-29 更新2026-07-21 收录

肺动脉高压分子机制

红藻转录组学

数据链接：

https://www.ebi.ac.uk/biostudies/ArrayExpress/studies/E-GEOD-33463 数据链接链接失效反馈

官方服务：

资源简介：

Erythroid-Specific Transcriptional Changes in PBMCs from Pulmonary Hypertension Patients

应用场景：

创建时间：

2012-04-29

肺动脉高压分子机制

MicroRNA调控

Pulmonary hypertension (PH) is a progressive and often fatal disorder whose pathogenesis involves pulmonary artery smooth muscle cell (PASMC) proliferation. Although modern PH therapies have significa

NIAID Data Ecosystem80

Systematic RNAseq Analysis of the Rat Pulmonary Arterial Hypertension Lung

肺动脉高压分子机制

RNA测序基因表达分析

RNAseq analysis of lung samples to identify differentially expressed genes and dysregulated pathways in a rat model of pulmonary arterial hypertension.

NIAID Data Ecosystem70

Galdieria sulphuraria SAG 21.92 Gene Expression Profiling - As_RNA_SAG_CTRL_7B transcriptome

极端环境基因表达

红藻转录组学

Galdieria sulphuraria SAG21.92 Gene Expression Profiling; control sample

NIAID Data Ecosystem60

A critical role of microRNAs in human pulmonary arterial hypertension. miR-204: a novel therapeutic target

肺动脉高压分子机制

miRNA治疗靶点

This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

NIAID Data Ecosystem80

E2F1 mediates SOX17 Deficiency-Induced Pulmonary Hypertension. E2F1 mediates SOX17 Deficiency-Induced Pulmonary Hypertension

肺动脉高压分子机制

内皮细胞转录调控

SRY-Box Transcription Factor 17 (SOX17) enhancers variants and mutations are found in patients with pulmonary arterial hypertension (PAH). In human PAH pulmonary microvascular endothelial cells (HPMVE

NIAID Data Ecosystem70

Erythroid-Specific Transcriptional Changes in PBMCs from Pulmonary Hypertension Patients

资源简介：

相关数据集